Bile duct Cancer
454 clinical trials
23 cell line models
0 approved drugs
Bile duct Cancer
Molecular Synopsis
Drugs and clinical candidates

No drugs have received FDA approval for Bile duct Cancer:

    115 drugs have a clinical trial registered for Bile duct Cancer.

    303 compounds have been tested in Bile duct Cancer (271 <= 500nM potency).

    Sources:,, ChEMBL.

    Clinical trials
    There are 454 clinical trials for Bile duct Cancer, 254 of which have one or more drug interventions, 200 with no drug intervention.
    Cell line models

    There are 23 Cell Line Models for Bile duct Cancer.

    Source: COSMIC
    Cell line models

    Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

    The following terms have been mapped from mesh condition terms to Bile duct Cancer:
    • Biliary Tract Neoplasms
    • Common Bile Duct Neoplasms
    • Klatskin's Tumor
    • Bile Duct Neoplasms
    • Klatskin Tumor
    The following terms have been mapped from to Bile duct Cancer: